I rate Bio-Rad (NYSE:BIO) with a buy rating. I start by mentioning that the low growth perspective is the negative aspect.

If you're someone that likes to browse the top-rated games of the year on OpenCritic to keep up with the zeitgeist, you've ...

Indian markets plunged due to escalating tensions between India and Pakistan, with the Sensex and Nifty closing sharply lower ...

The trends on Gift Nifty also indicate a negative start for the Indian benchmark index. The Gift Nifty was trading around ...

A rare bullish outside day just formed on the S&P 500 Index (SPX) chart — here’s what history says to expect, and why it ...

"The difference between living or dying can rest on whether or not the doctor knows about a particular condition." ...

By Ahmed Tabaqchali, Chief Strategist of AFC Iraq Fund. Any opinions expressed are those of the author, and do not ...

The Q1 2025 analysis encompassed data from 28 commercial banks, 4 major telecommunications providers, and 4 leading ...

Santiment data shows that BTC dormant wallets are moving; if tokens are sent to exchanges, the selling pressure could ...

Roger J Kerr says populist politicians promising the earth to get elected, invariably get found out when they discover it is ...

Price manipulation by big quant shops and retail investors' meme stock trades lead overnight price appreciation to be much ...

Realized volatility continues to skyrocket, which is not positive for the stock market. A volatile market is generally a dangerous one and can easily turn bearish. Yet this doesn't seem to bother the ...